Capsugel® Zephyr™ Technical Brief

Dry-powder inhalation capsules provide a maior drug development opportunity for pulmonary treatments and systemic applications. 

Lonza's Capsugel® Zephyr™ Dry-Powder Inhalation Capsule Portfolio offers the most complete portfolio of DPl capsules with targeted emitted dose that are tailored toward formulation properties and inhalation device. The high-quality customizable capsule solutions based on different polymers and compositions are supported by a wide range of services within Lonza Pharma & Biotech. 


To View, Please Provide the Following

To access all of the latest news, white papers, webinars and knowledge center resources, Create An Account. Already have a Capsugel account? Log In

To view this item, Sign Up for a free account

Get access to the latest news, additional whitepapers, webinars and Knowledge Center content. Already have an account? Log In

Thanks for creating an account with Capsugel!

You now have access to the latest news, whitepapers, webinars and Knowledge Center content.

Thank you for your interest.

If you have any questions, our experts are here to help.

Continue Browsing Privacy Policy